litlas
Log inCreate account

Bjoern Chapuy

Active 2007–2025

72
Papers
19,128
Citations
50
h-index
66
i10-index

Citations

Citations per year for Bjoern Chapuy2001: 1 citations2003: 2 citations2004: 1 citations2005: 1 citations2006: 7 citations2008: 3 citations2009: 8 citations2010: 3 citations2011: 23 citations2012: 62 citations2013: 110 citations2014: 159 citations2015: 335 citations2016: 412 citations2017: 453 citations2018: 407 citations2019: 1,072 citations2020: 1,089 citations2021: 1,042 citations2022: 717 citations2023: 562 citations2024: 810 citations2025: 314 citations2026: 9 citations2002: no citations, so this year is not shown2007: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,623 citing papers, 26.8% of this breakdownChina: 1,375 citing papers, 14.1% of this breakdownGermany: 620 citing papers, 6.3% of this breakdownUnited Kingdom: 495 citing papers, 5.1% of this breakdownItaly: 495 citing papers, 5.1% of this breakdownFrance: 439 citing papers, 4.5% of this breakdownCanada: 342 citing papers, 3.5% of this breakdownSpain: 341 citing papers, 3.5% of this breakdownJapan: 318 citing papers, 3.2% of this breakdownSwitzerland: 272 citing papers, 2.8% of this breakdownAustralia: 211 citing papers, 2.2% of this breakdownNetherlands: 208 citing papers, 2.1% of this breakdown
0%26.8%Other 20.8%

Institutions

Fields

  • Medicine60.2%
  • Biochemistry, Genetics and Molecular Biology29.9%
  • Immunology and Microbiology8.2%
  • Engineering0.4%
  • Computer Science0.3%
  • Chemistry0.2%
  • Other0.8%

Topics

  • Lymphoma Diagnosis and Treatment9.6%
  • Cancer Immunotherapy and Biomarkers8.6%
  • CAR-T cell therapy research5.9%
  • Immune Cell Function and Interaction5.6%
  • Immunotherapy and Immune Responses3.4%
  • Chronic Lymphocytic Leukemia Research3.1%
  • Other63.8%

Coauthors

All papers

Open in search
  1. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

    Authors: Bjoern Chapuy, Chip Stewart, Andrew Dunford, Jaegil Kim, Atanas Kamburov, Robert Redd, Mike S. Lawrence, Margaretha G.M. Roemer, Amy J. Li, Marita Ziepert, Annette M. Staiger, Jeremiah A. Wala, Matthew D. Ducar, Ignaty Leshchiner, Ester Rheinbay, Amaro Taylor‐Weiner, Caroline A. Coughlin, Julian M. Hess, Chandra Sekhar Pedamallu, Dimitri Livitz, Daniel Rosebrock, Mara Rosenberg, Adam Tracy, Heike Horn, Paul Van Hummelen, Andrew L. Feldman, Brian K. Link, Anne J. Novak, James R. Cerhan, Thomas M. Habermann, Reiner Siebert, Andreas Rosenwald, Aaron R. Thorner, Matthew Meyerson, Todd R. Golub, Rameen Beroukhim, Gerald Wulf, German Ott, Scott J. Rodig, Stefano Monti, Donna Neuberg, Markus Loeffler, Michael Pfreundschuh, Lorenz Trümper, Gad Getz, Margaret A. Shipp - Nature Medicine 2018 cited by 1,972

  2. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

    Authors: Stephen M. Ansell, Alexander M. Lesokhin, Ivan Borrello, Ahmad Halwani, Emma C. Scott, Martin Gutierrez, Stephen J. Schuster, Michael Millenson, Deepika Cattry, Gordon J. Freeman, Scott J. Rodig, Bjoern Chapuy, Azra H. Ligon, Lili Zhu, Joseph F. Grosso, Su Young Kim, John M. Timmerman, Margaret A. Shipp, Philippe Armand - New England Journal of Medicine 2014 cited by 3,547

  3. PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

    Authors: Margaretha G.M. Roemer, Ranjana H. Advani, Azra H. Ligon, Yasodha Natkunam, Robert Redd, Heather Homer, Courtney Connelly, Heather H. Sun, Sarah E. Daadi, Gordon J. Freeman, Philippe Armand, Bjoern Chapuy, Daphne de Jong, Richard T. Hoppe, Donna Neuberg, Scott J. Rodig, Margaret A. Shipp - Journal of Clinical Oncology 2016 cited by 803

  4. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma

    Authors: Michael R. Green, Stefano Monti, Scott J. Rodig, Przemysław Juszczyński, Treeve Currie, Evan A. O’Donnell, Bjoern Chapuy, Kunihiko Takeyama, Donna Neuberg, Todd R. Golub, Jeffery L. Kutok, Margaret A. Shipp - Blood 2010 cited by 1,297

  5. Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma

    Authors: Pilar Caro, Amar U. Kishan, Erik Norberg, Illana A. Stanley, Bjoern Chapuy, Scott B. Ficarro, Klaudia Polak, Daniel Tondera, John Gounarides, Hong Yin, Feng Zhou, Michael R. Green, Lin‐Feng Chen, Stefano Monti, Jarrod A. Marto, Margaret A. Shipp, Nika N. Danial - Cancer Cell 2012 cited by 528

  6. Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

    Authors: Alexander M. Lesokhin, Stephen M. Ansell, Philippe Armand, Emma Scott, Ahmad Halwani, Martin Gutierrez, Michael Millenson, Adam D. Cohen, Stephen J. Schuster, Daniel Lebovic, Madhav V. Dhodapkar, David Avigan, Bjoern Chapuy, Azra H. Ligon, Gordon J. Freeman, Scott J. Rodig, Deepika Cattry, Lili Zhu, Joseph F. Grosso, M. Brigid Garelik, Margaret A. Shipp, Ivan Borrello, John M. Timmerman - Journal of Clinical Oncology 2016 cited by 1,011

  7. PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies

    Authors: Benjamin J. Chen, Bjoern Chapuy, Jing Ouyang, Heather H. Sun, Margaretha G.M. Roemer, Mina L. Xu, Hongbo Yu, Christopher D.�M. Fletcher, Gordon J. Freeman, Margaret A. Shipp, Scott J. Rodig - Clinical Cancer Research 2013 cited by 839

  8. Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma

    Authors: Bjoern Chapuy, Michael R. McKeown, Charles Y. Lin, Stefano Monti, Margaretha G.M. Roemer, Jun Qi, Peter B. Rahl, Heather H. Sun, Kelly T. Yeda, John G. Doench, Elaine C. Reichert, Andrew L. Kung, Scott J. Rodig, Richard A. Young, Margaret A. Shipp, James E. Bradner - Cancer Cell 2013 cited by 766

  9. The proteogenomic subtypes of acute myeloid leukemia

    Authors: Ashok Kumar Jayavelu, Sebastian Wolf, Florian Buettner, Gabriela Alexe, Björn Häupl, Federico Comoglio, Constanze Schneider, Carmen Doebele, Dominik C. Fuhrmann, Sebastian Wagner, Elisa Donato, Carolin Andresen, Anne C. Wilke, Alena Zindel, Dominique Jahn, Bianca Splettstoesser, Uwe Plessmann, Silvia Münch, Khali Abou-El-Ardat, Philipp Makowka, Fabian Acker, Julius C. Enßle, Anjali Cremer, Frank Schnütgen, Nina Kurrle, Bjoern Chapuy, Jens Löber, Sylvia Hartmann, Peter J. Wild, Ilka Wittig, Daniel Hübschmann, Lars Kaderali, Jürgen Cox, Bernhard Brüne, Christoph Röllig, Christian Thiede, Björn Steffen, Martin Bornhäuser, Andreas Trumpp, Henning Urlaub, Kimberly Stegmaier, Hubert Serve, Matthias Mann, Thomas Oellerich - Cancer Cell 2022 cited by 147

  10. Targetable genetic features of primary testicular and primary central nervous system lymphomas

    Authors: Bjoern Chapuy, Margaretha G.M. Roemer, Chip Stewart, Yuxiang Tan, Ryan Abo, Liye Zhang, Andrew Dunford, David M. Meredith, Aaron R. Thorner, Ekaterina S. Jordanova, Gang Liu, Friedrich Feuerhake, Matthew D. Ducar, Gerald Illerhaus, Daniel Gusenleitner, Erica Linden, Heather H. Sun, Heather Homer, Miyuki Aono, Geraldine S. Pinkus, Azra H. Ligon, Keith L. Ligon, Judith A. Ferry, Gordon J. Freeman, Paul Van Hummelen, Todd R. Golub, Gad Getz, Scott J. Rodig, Daphne de Jong, Stefano Monti, Margaret A. Shipp - Blood 2015 cited by 599

  11. NLRC5/MHC class I transactivator is a target for immune evasion in cancer

    Authors: Sayuri Yoshihama, Jason Roszik, Isaac Downs, Torsten Meißner, Saptha Vijayan, Bjoern Chapuy, Tabasum Sidiq, Margaret A. Shipp, Gregory Lizée, Koichi S. Kobayashi - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 270

  12. TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer

    Authors: Mengyu Tu, Lukas Klein, Elisa Espinet, Theodoros Georgomanolis, Florian Wegwitz, Xiaojuan Li, Laura Urbach, Adi Danieli‐Mackay, Stefan Küffer, Kamil Bojarczuk, Athanasia Mizi, Ufuk Günesdogan, Bjoern Chapuy, Zuguang Gu, Albrecht Neeße, Uday Kishore, Philipp Ströbel, Elisabeth Heßmann, Stephan A. Hahn, Andreas Trumpp, Argyris Papantonis, Volker Ellenrieder, Shiv K. Singh - Nature Cancer 2021 cited by 117

  13. PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma

    Authors: Lakshmi Nayak, Fábio M. Iwamoto, Ann S. LaCasce, Srinivasan Mukundan, Margaretha G.M. Roemer, Bjoern Chapuy, Philippe Armand, Scott J. Rodig, Margaret A. Shipp - Blood 2017 cited by 459

  14. Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels

    Authors: Tobias Roider, Julian Seufert, Alexey Uvarovskii, Felix Frauhammer, Marie Bordas, Nima Abedpour, Marta Stolarczyk, Jan‐Philipp Mallm, Sophie A. Herbst, Peter‐Martin Bruch, Hyatt Balke‐Want, Michael Hundemer, Karsten Rippe, Benjamin Goeppert, Martina Seiffert, Benedikt Brors, Gunhild Mechtersheimer, Thorsten Zenz, Martin Peifer, Bjoern Chapuy, Matthias Schlesner, Carsten Müller‐Tidow, Stefan Fröhling, Wolfgang Huber, Simon Anders, Sascha Dietrich - Nature Cell Biology 2020 cited by 179

  15. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

    Authors: Jens G. Lohr, Petar Stojanov, Michael S. Lawrence, Daniel Auclair, Bjoern Chapuy, Carrie Sougnez, Peter Cruz‐Gordillo, Birgit Knoechel, Yan W. Asmann, Susan L. Slager, Anne J. Novak, Ahmet Doǧan, Stephen M. Ansell, Brian K. Link, Lihua Zou, Joshua Gould, Gordon Saksena, Nicolas Stransky, Claudia Rangel‐Escareño, Juan Carlos Fernández-López, Alfredo Hidalgo‐Miranda, Jorge Meléndez-Zajgla, Enrique Hernández–Lemus, Angela Schwarz‐Cruz y Celis, Iván Imaz-Rosshandler, Akinyemi I. Ojesina, Joonil Jung, Chandra Sekhar Pedamallu, Eric S. Lander, Thomas M. Habermann, James R. Cerhan, Margaret A. Shipp, Gad Getz, Todd R. Golub - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 980

  16. Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer

    Authors: Uta M. Demel, Marlitt Böger, Schayan Yousefian, Corinna Grunert, Le Zhang, Paul W. Hotz, Adrian Gottschlich, Hazal Köse, Konstandina Isaakidis, Dominik Vonficht, Florian Grünschläger, Elena Rohleder, Kristina Wagner, Judith Dönig, Veronika Igl, Bernadette Brzezicha, Francis Baumgartner, Stefan Habringer, Jens Löber, Bjoern Chapuy, Carl Weidinger, Sebastian Kobold, Simon Haas, Antonia Busse, Stefan Müller, Matthias Wirth, Markus Schick, Ulrich Keller - Journal of Clinical Investigation 2022 cited by 84

  17. Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma

    Authors: Marco Fangazio, Erik Ladewig, Karen Gomez, Laura Garcia‐Ibanez, Rahul Kumar, Julie Teruya‐Feldstein, Davide Rossi, Ioan Filip, Qiang Pan‐Hammarström, Giorgio Inghirami, Renzo Boldorini, German Ott, Annette M. Staiger, Bjoern Chapuy, Gianluca Gaïdano, Govind Bhagat, Katia Basso, Raúl Rabadán, Laura Pasqualucci, Riccardo Dalla‐Favera - National Academy of Sciences, Proceedings of the National Academy of Sciences 2021 cited by 93

  18. Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status

    Authors: Margaretha G.M. Roemer, Ranjana H. Advani, Robert Redd, Geraldine S. Pinkus, Yasodha Natkunam, Azra H. Ligon, Courtney Connelly, Christine J. Pak, Christopher D. Carey, Sarah E. Daadi, Bjoern Chapuy, Daphne de Jong, Richard T. Hoppe, Donna Neuberg, Margaret A. Shipp, Scott J. Rodig - Cancer Immunology Research 2016 cited by 191

  19. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3

    Authors: Thiha Aung, Bjoern Chapuy, Daniel Vogel, Dirk Wenzel, Martin Oppermann, Marlen Lahmann, Toni Weinhage, Kerstin Menck, Timo Hupfeld, Raphael Koch, Lorenz Trümper, Gerald Wulf - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 359

  20. Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion

    Authors: Kirsty Wienand, Bjoern Chapuy, Chip Stewart, Andrew Dunford, David Wu, Jaegil Kim, Atanas Kamburov, Timothy R. Wood, Fathima Zumla Cader, Matthew D. Ducar, Aaron R. Thorner, Anwesha Nag, Alexander T. Heubeck, Michael Buonopane, Robert Redd, Kamil Bojarczuk, Lee N. Lawton, Philippe Armand, Scott J. Rodig, Jonathan R. Fromm, Gad Getz, Margaret A. Shipp - Blood Advances 2019 cited by 165

  21. Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia

    Authors: Shuo-Chieh Wu, Loretta S. Li, Nadja Kopp, Joan Montero, Bjoern Chapuy, Akinori Yoda, Amanda L. Christie, Huiyun Liu, Alexandra Christodoulou, Diederik van Bodegom, Jordy Van Der Zwet, Jacob V. Layer, Trevor Tivey, Andrew A. Lane, Jeremy Ryan, Samuel Y. Ng, Daniel J. DeAngelo, Richard M. Stone, David P. Steensma, Martha Wadleigh, Marian H. Harris, Emeline Mandon, Nicolas Ebel, Rita Andraos, Vincent Romanet, Arno Dölemeyer, Dario Sterker, Michael Zender, Scott J. Rodig, Masato Murakami, Francesco Hofmann, Frank C. Kuo, Michael J. Eck, Lewis B. Silverman, Stephen E. Sallan, Anthony Letai, Fabienne Baffert, Eric Vangrevelinghe, Thomas Radimerski, Christoph Gaul, David M. Weinstock - Cancer Cell 2015 cited by 123

  22. Molecular and clinical diversity in primary central nervous system lymphoma

    Authors: Isaias Hernández-Verdín, E. Kirasic, Kirsty Wienand, Karima Mokhtari, Sandrine Eimer, H. Loiseau, Audrey Rousseau, Jérôme Paillassa, Guido Ahle, Felix Lerintiu, Emmanuelle Uro‐Coste, Lucie Obéric, Dominique Figarella‐Branger, Olivier Chinot, Guillaume Gauchotte, Luc Taillandier, JP Marolleau, M. Polivka, Clovis Adam, Rénata Ursu, Anna Schmitt, N. Barillot, Lucia Nichelli, Fernando Lozano-Sanchez, M.-J. Ibañez-Juliá, Matthieu Peyre, Bertrand Mathon, Yah-se Abada, Frédéric Charlotte, Frédéric Davi, Chip Stewart, Aurélien de Reyniès, Sylvain Choquet, Carole Soussain, Caroline Houillier, Bjoern Chapuy, Khê Hoang‐Xuan, Agustí Alentorn - Annals of Oncology 2022 cited by 83

  23. EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity

    Authors: Maher K. Gandhi, Thanh Hoang, Soi Cheng Law, Sandra Brosda, Kacey O’Rourke, Joshua W.D. Tobin, Frank Vari, Valentine Murigneux, J. Lynn Fink, Jay Gunawardana, Clare Gould, Harald Oey, Karolina Bednarska, Susanne Delécluse, Ralf Ulrich Trappe, Lilia Merida de Long, Muhammed B. Sabdia, Govind Bhagat, Greg Hapgood, Emily Blyth, Luke Clancy, Joel Wight, Eliza A. Hawkes, Lisa M. Rimsza, A. Maguire, Kamil Bojarczuk, Bjoern Chapuy, Colm Keane - Blood 2020 cited by 119

  24. Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell–rich and exhausted T-effector microenvironment

    Authors: Fathima Zumla Cader, Ron C.J. Schackmann, Xihao Hu, Kirsty Wienand, Robert Redd, Bjoern Chapuy, Jing Ouyang, Nicole Paul, Evisa Gjini, Mikel Lipschitz, Philippe Armand, David Wu, Jonathan R. Fromm, Donna Neuberg, X. Shirley Liu, Scott J. Rodig, Margaret A. Shipp - Blood 2018 cited by 165